ABSTRACT
A total of 40 patients with non-gonococcal urethritis (NGU) were divided into two groups. Twenty patients of group 1 received standard antibacterial treatment while 20 patients of group 2 received the same treatment plus an immunotropic drug based on tiloron (lavomax) in a course dose 1.25 g. Patients of group 2 had no recurrences while in group 1 recurrences were seen in 25% patients. Addition of lavomax resulted in clinical and etiological cure and activation of local (secretory IgA) and systemic (interferons alpha and gamma in blood serum) factors in anti-infection defense in NGU patients.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/adverse effects , Tilorone/administration & dosage , Tilorone/adverse effects , Urethritis/drug therapy , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Humans , Immunoglobulin A/blood , Interferon-alpha/blood , Interferon-gamma/blood , Male , Middle Aged , Urethritis/blood , Urethritis/microbiologyABSTRACT
Analyses of the results of epidemiologic studies of the incidence of coronary heart disease (CHD) and the planning of preventive programs should take into account independent predictive values of the diagnostic criteria of suspected CHD. The risk of cardiovascular death is found to be 3 times as high in individuals with suspected CHD as it is in those showing no CHD signs.
Subject(s)
Coronary Disease/epidemiology , Adult , Age Factors , Cerebrovascular Disorders/epidemiology , Cerebrovascular Disorders/mortality , Coronary Disease/diagnosis , Coronary Disease/mortality , Electrocardiography , Humans , Male , Mass Screening , Middle Aged , Moscow , Prognosis , Sex Factors , Urban PopulationSubject(s)
Coronary Disease/epidemiology , Echocardiography , Electrocardiography , Mass Screening , Adult , Coronary Disease/diagnosis , Humans , Male , Middle Aged , Moscow , Urban PopulationABSTRACT
ECG assessment after the Minnesota code with defining "definite" CHD and "expected" CHD was used as one of the criteria of establishing diagnosis in mass screening of the population to find out CHD prevalence. A profound clinico-instrumental study of 100 men aged 20 to 59 with "expected" CHD showed that in 16% ECG-changes reflected true CHD, in 42% they were determined by noncoronarogenic causes. In 42% of the cases cardiovascular pathology was undetectable among the persons with "expected" CHD. Significant incidence of the noncoronarogenic pathology in the population is of interest to research.